Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Companyโs technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the userโs mobile device.
์ฑ์ฅ ์ค
ํ์ฌ๋ ์ฑ์ฅ ๋จ๊ณ์ ์์ผ๋ฉฐ, ์ต์ ์ฐ๊ฐ ์์ต์ ๋ฏธํ 3.92M์ ๋ฌํฉ๋๋ค.
๊ณ ์์ต ์ฑ์ฅ
ํ์ฌ์ ์์ด์ต์ ์
๊ณ ์ ๋๋ฅผ ๋ฌ๋ฆฌ๊ณ ์์ผ๋ฉฐ, ์ต๊ทผ ์ฐ๊ฐ ์์ด์ต์ ๋ฏธํ 164.35์ ๋ฌํฉ๋๋ค.
๊ณผ์ ํ๊ฐ๋
ํ์ฌ์ ์ต์ PE์ -0.38๋ก, ์ต๊ทผ 3๋
๊ธฐ์ค ๋ฎ์ ๋ฐฑ๋ถ์ ๋ฒ์์ ์ํฉ๋๋ค.
๊ธฐ๊ด ๋งค๋
์ต์ ๊ธฐ๊ด ๋ณด์ ์ฃผ์ ์๋ 8.91M์ฃผ์ด๋ฉฐ, ์ ๋ถ๊ธฐ ๋๋น 0.56% ๊ฐ์ํ์ต๋๋ค.
๋ ๋ฑ
๊ฐ๋๊ฐ ๋ณด์
์คํ ํฌ์์ ๋ ๋ฑ
๊ฐ๋์ด(๊ฐ) ์ด ์ฃผ์ 1.73M์ฃผ๋ฅผ ๋ณด์ ํ๊ณ ์์ต๋๋ค.
์์ฅ ํ๋ ์ฆ๊ฐ
ํ์ฌ๋ ํฌ์์๋ค์ ๊ด์ฌ์ด ๋์์ ธ, ์ต๊ทผ 20์ผ๊ฐ ํ์ ์จ์ด 10.46์
๋๋ค.